Skip to main content
. 2017 Apr 17;8(31):51200–51209. doi: 10.18632/oncotarget.17158

Table 3. Long term oncological outcome.

N= 10
Median follow-up (range) 54 (49-63)
Alive at end of follow-up 10/10
Local recurrence 0/10
Peritoneal metastases 0/10
Liver metastasis 0/10
Pulmonary metastasis 2/10
Other metastasis 0/10